Overview

Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

Status:
Unknown status

Trial end date:
2018-12-31

Target enrollment:

Participant gender:

Summary

The benefit of current stem cell transplantation therapy for myocardial infarction is limited by low survival rate for stem cell. The purpose of this study is to test whether intensive Atorvastatin therapy can improve the outcome of patients with impaired left ventricle function after acute myocardial infarction who underwent intracoronary transfer of autologous bone marrow mesenchymal stem cells.

Phase:

Phase 2

Details

Lead Sponsor:

Yuejin Yang

Collaborators:

Peking Union Medical College Hospital
The First Hospital of Hebei Medical University
Zunyi Medical College

Treatments:

Atorvastatin
Atorvastatin Calcium